Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia.

[1]  F. Haj,et al.  Podocyte‐specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury , 2017, The FEBS journal.

[2]  F. Lin.  Autophagy in renal tubular injury and repair , 2017, Acta physiologica.

[3]  F. Haj,et al.  Protein tyrosine phosphatase Shp2 deficiency in podocytes attenuates lipopolysaccharide-induced proteinuria , 2017, Scientific Reports.

[4]  Y. Isaka,et al.  Autophagy Inhibits the Accumulation of Advanced Glycation End Products by Promoting Lysosomal Biogenesis and Function in the Kidney Proximal Tubules , 2017, Diabetes.

[5]  E. Schleicher,et al.  The impact of insulin resistance on the kidney and vasculature , 2016, Nature Reviews Nephrology.

[6]  M. Xie,et al.  Soluble epoxide hydrolase inhibition provides multi-target therapeutic effects in rats after spinal cord injury , 2016, Molecular Neurobiology.

[7]  S. Griffey,et al.  Soluble Epoxide Hydrolase Pharmacological Inhibition Ameliorates Experimental Acute Pancreatitis in Mice , 2015, Molecular Pharmacology.

[8]  F. Haj,et al.  Endoplasmic reticulum stress in the peripheral nervous system is a significant driver of neuropathic pain , 2015, Proceedings of the National Academy of Sciences.

[9]  M. Madero,et al.  Biomarkers in chronic kidney disease, from kidney function to kidney damage. , 2015, World journal of nephrology.

[10]  Mary E. Choi,et al.  Autophagy in diabetic nephropathy. , 2014, The Journal of endocrinology.

[11]  K. Yokote,et al.  Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes , 2014, Journal of diabetes investigation.

[12]  L. Chawla,et al.  Biomarkers of renal function, which and when? , 2015, Clinica chimica acta; international journal of clinical chemistry.

[13]  S. Hwang,et al.  Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: Role for omega-3 epoxides , 2014, Proceedings of the National Academy of Sciences.

[14]  S. Griffey,et al.  Effects of Soluble Epoxide Hydrolase Deficiency on Acute Pancreatitis in Mice , 2014, PloS one.

[15]  Jinu Kim,et al.  Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation. , 2014, American journal of physiology. Renal physiology.

[16]  J. Forbes,et al.  Stress in the kidney is the road to pERdition: is endoplasmic reticulum stress a pathogenic mediator of diabetic nephropathy? , 2014, The Journal of endocrinology.

[17]  H. Frucht,et al.  Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection. , 2014, World journal of gastroenterology.

[18]  F. Hu,et al.  The global implications of diabetes and cancer , 2014, The Lancet.

[19]  Katalin Susztak,et al.  Molecular mechanisms of diabetic kidney disease. , 2014, The Journal of clinical investigation.

[20]  Jinghong Zhao,et al.  Rapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic mice , 2014, Molecular and Cellular Biochemistry.

[21]  J. Mehta,et al.  High Fat Diet Causes Renal Fibrosis in LDLr-null Mice Through MAPK-NF-&kgr;B Pathway Mediated by Ox-LDL , 2014, Journal of cardiovascular pharmacology.

[22]  Mary E. Choi,et al.  Autophagy in kidney health and disease. , 2014, Antioxidants & redox signaling.

[23]  T. Uzu,et al.  Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions. , 2013, Journal of the American Society of Nephrology : JASN.

[24]  H. Mischak,et al.  Long Term Metabolic Syndrome Induced by a High Fat High Fructose Diet Leads to Minimal Renal Injury in C57BL/6 Mice , 2013, PloS one.

[25]  P. Light,et al.  Epoxyeicosatrienoic acids protect cardiac cells during starvation by modulating an autophagic response , 2013, Cell Death and Disease.

[26]  J. Miner,et al.  The glomerular basement membrane as a barrier to albumin , 2013, Nature Reviews Nephrology.

[27]  B. Hammock,et al.  Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model. , 2013, Prostaglandins & other lipid mediators.

[28]  J. Imig.  Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function. , 2013, Prostaglandins & other lipid mediators.

[29]  Lei Jiang,et al.  Autophagy Attenuates Diabetic Glomerular Damage through Protection of Hyperglycemia-Induced Podocyte Injury , 2013, PloS one.

[30]  H. Koepsell,et al.  Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus. , 2013, American journal of physiology. Renal physiology.

[31]  B. Hammock,et al.  Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications. , 2012, Journal of medicinal chemistry.

[32]  Patrick J Heagerty,et al.  Temporal trends in the prevalence of diabetic kidney disease in the United States. , 2011, JAMA.

[33]  Q. Pang,et al.  Attenuation of diabetic nephropathy in diabetes rats induced by streptozotocin by regulating the endoplasmic reticulum stress inflammatory response. , 2011, Metabolism: clinical and experimental.

[34]  John D Imig,et al.  Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin‐induced type 1 diabetes , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

[35]  C. Cohen,et al.  Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. , 2010, The Journal of clinical investigation.

[36]  G. Hotamisligil,et al.  Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease , 2010, Cell.

[37]  J. Gerich.  Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[38]  Shuyan Wu,et al.  Rapamycin induces autophagy and exacerbates metabolism associated complications in a mouse model of type 1 diabetes. , 2010, Indian journal of experimental biology.

[39]  B. Hammock,et al.  Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension. , 2009, American journal of physiology. Renal physiology.

[40]  R A Knight,et al.  Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes , 2009, Cell Death and Differentiation.

[41]  S. Imaoka,et al.  Regulation of soluble epoxide hydrolase (sEH) in mice with diabetes: high glucose suppresses sEH expression. , 2009, Drug metabolism and pharmacokinetics.

[42]  Jun Yang,et al.  Effect of Taurine-Conjugated Ursodeoxycholic Acid on Endoplasmic Reticulum Stress and Apoptosis Induced by Advanced Glycation End Products in Cultured Mouse Podocytes , 2008, American Journal of Nephrology.

[43]  P. Walter,et al.  Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.

[44]  A. A. Spector,et al.  Action of epoxyeicosatrienoic acids on cellular function. , 2007, American journal of physiology. Cell physiology.

[45]  B. Kestenbaum,et al.  Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. , 2007, Journal of the American Society of Nephrology : JASN.

[46]  W. K. Bolton,et al.  Renal function testing. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[47]  B. Hammock,et al.  An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive Hypertension , 2005, Hypertension.

[48]  G. Wolf,et al.  From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. , 2005, Diabetes.

[49]  D. Grant,et al.  Distribution of Soluble Epoxide Hydrolase and of Cytochrome P450 2C8, 2C9, and 2J2 in Human Tissues , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[50]  A. Bolzán,et al.  Genotoxicity of streptozotocin. , 2002, Mutation research.

[51]  B. Hammock,et al.  Soluble Epoxide Hydrolase Inhibition Lowers Arterial Blood Pressure in Angiotensin II Hypertension , 2002, Hypertension.

[52]  B D Hammock,et al.  Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids , 2000, Circulation research.

[53]  K. Ley,et al.  Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. , 1999, Science.

[54]  U. Pfeifer,et al.  Inhibition and restimulation by insulin of cellular autophagy in distal tubular cells of the kidney in early diabetic rats. , 1997, Kidney & blood pressure research.

[55]  M. Stumvoll,et al.  Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine. , 1995, The Journal of clinical investigation.

[56]  E. O'Brien,et al.  The J-shaped curve in elderly hypertensives. , 1992, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[57]  V. Totović,et al.  Inhibition of cellular autophagy in proximal tubular cells of the kidney in streptozotocin-diabetic and uninephrectomized rats , 1992, Virchows Archiv. B, Cell pathology including molecular pathology.